4//SEC Filing
MIDDLEKAUFF W BRADFORD 4
Accession 0001127602-18-009885
CIK 0001472091other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 1:56 PM ET
Size
5.2 KB
Accession
0001127602-18-009885
Insider Transaction Report
Form 4
MIDDLEKAUFF W BRADFORD
Senior VP, GC and Secretary
Transactions
- Award
Stock Option (Right To Purchase)
2018-03-01+65,000→ 65,000 totalExercise: $14.98Exp: 2028-03-01→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 65,000 shares of Common Stock, will become exercisable on March 1, 2019, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001214501
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 1:56 PM ET
- Size
- 5.2 KB